We are live on ! Find out more
MRCM

M&R Capital Management Portfolio holdings

AUM $454M
1-Year Est. Return 40.11%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
+40.11%
3 Year Est. Return
+52.56%
5 Year Est. Return
+141.03%
10 Year Est. Return
+275.44%
AUM
$419M
AUM Growth
+$10.9M
Cap. Flow
+$2.31M
Cap. Flow %
0.55%
Top 10 Hldgs %
47.82%
Holding
559
New
11
Increased
126
Reduced
102
Closed
12

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$8.37M
2
CACI icon
CACI
CACI
+$5.74M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$2.32M
4
PEP icon
PepsiCo
PEP
+$1.38M
5
ACGL icon
Arch Capital
ACGL
+$1.25M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$8.98M
2
CMCSA icon
Comcast
CMCSA
+$2.47M
3
LW icon
Lamb Weston
LW
+$2.32M
4
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$1.3M
5
MMM icon
3M
MMM
+$1.04M

Sector Composition

Rank Sector Weight
1 Technology 27.36%
2 Financials 20.03%
3 Healthcare 10.65%
4 Communication Services 9.1%
5 Consumer Discretionary 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TJX icon
51
TJX Companies
TJX
$149B
$1.38M 0.33%
12,507
+1,141
+10% +$115K
PSX icon
52
Phillips 66
PSX
$97.4B
$1.24M 0.3%
8,814
+401
+5% +$59.4K
XLK icon
53
State Street Technology Select Sector SPDR ETF
XLK
$121B
$1.24M 0.3%
10,940
-14
-0.1% -$1.47K
SYK icon
54
Stryker
SYK
$127B
$1.19M 0.28%
3,504
CVX icon
55
Chevron
CVX
$396B
$1.11M 0.27%
7,109
MDLZ icon
56
Mondelez International
MDLZ
$79.6B
$1.06M 0.25%
16,153
+78
+0.5% +$5.35K
AFL icon
57
Aflac
AFL
$58.4B
$1.06M 0.25%
11,816
+7
+0.1% +$602
CNI icon
58
Canadian National Railway
CNI
$76.2B
$1.05M 0.25%
8,884
CMCSA icon
59
Comcast
CMCSA
$96B
$1.04M 0.25%
26,458
-63,042
-70% -$2.47M
NEE icon
60
NextEra Energy
NEE
$171B
$961K 0.23%
13,571
+20
+0.1% +$1.42K
MCD icon
61
McDonald's
MCD
$188B
$925K 0.22%
3,631
-484
-12% -$128K
PFE icon
62
Pfizer
PFE
$159B
$924K 0.22%
33,033
-3,521
-10% -$96.9K
BNY
63
Bank of New York Mellon
BNY
$110B
$902K 0.22%
15,061
+16
+0.1% +$926
LIN icon
64
Linde
LIN
$226B
$866K 0.21%
1,974
+530
+37% +$233K
BX icon
65
Blackstone
BX
$107B
$839K 0.2%
6,777
-820
-11% -$101K
CI icon
66
Cigna
CI
$73.7B
$824K 0.2%
2,494
+102
+4% +$35.2K
ALL icon
67
Allstate
ALL
$65.9B
$795K 0.19%
4,979
HON icon
68
Honeywell
HON
$68.9B
$770K 0.18%
3,827
-105
-3% -$20K
COP icon
69
ConocoPhillips
COP
$157B
$753K 0.18%
6,587
BAC icon
70
Bank of America
BAC
$436B
$726K 0.17%
18,265
-1,928
-10% -$73.9K
HSIC icon
71
Henry Schein
HSIC
$9.98B
$708K 0.17%
11,038
SNV
72
DELISTED
Synovus
SNV
$701K 0.17%
17,434
-527
-3% -$20K
SLB icon
73
SLB Ltd
SLB
$85.1B
$688K 0.16%
14,576
+137
+0.9% +$6.61K
ADP icon
74
Automatic Data Processing
ADP
$114B
$651K 0.16%
2,726
+2
+0.1% +$491
LSXMK
75
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$599K 0.14%
27,049
-5,699
-17% -$136K

Similar funds

M&R Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, M&R Capital Management held 559 positions worth $419M, up 2.7% from $408M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Trading was light in Q2 2024: portfolio turnover was 4.1%. M&R Capital Management opened 11 new positions and exited 12, leaving the 559-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • M&R Capital Management's largest Q2 2024 buy was KeyCorp: 11,973 shares worth $170K.
  • M&R Capital Management added most to AstraZeneca in Q2 2024, an estimated $8.37M increase.
  • M&R Capital Management's biggest Q2 2024 reduction was CVS Health, cutting an estimated $8.98M.
  • M&R Capital Management fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $42.7K.
  • M&R Capital Management's ten largest holdings make up 48% of its $419M portfolio in Q2 2024.
  • M&R Capital Management opened 11 new positions and closed 12 in Q2 2024.
  • M&R Capital Management's portfolio value rose 2.7% quarter-over-quarter to $419M.

Based on M&R Capital Management's 13F filing for Q2 2024, filed 2 Jul 2024.